Viewing nowCombinationSebaco HCT Tablet 5/20/12.5 mg
Olmesartan Medoxomil 20mg · Amlodipine Besylate 6.944mg +1 more
Tablet · Prescription medication · Combination
Aju Pharmaceuticals Co., Ltd.

MFDS item code 201906790 · Approved 2019.09.25 · Insurance code 654005520
Treatment of essential hypertension not controlled with combination therapy
This drug is used in patients with essential hypertension who find it difficult to control blood pressure with a single medication. It effectively lowers blood pressure, helping to reduce the risk of cardiovascular diseases. It is used to maintain the overall health of patients by improving hypertension management.
Take 1 tablet once daily with water, regardless of meals. If possible, it is recommended to take it at the same time each day (e.g., in the morning). Before administering this medicine, it is recommended to adjust the dose using the individual ingredients (amlodipine and olmesartan medoxomil, as monotherapy or combination therapy). However, if blood pressure is not controlled with amlodipine and olmesartan medoxomil combination therapy as described below, switching directly to this medicine may be considered. The maximum dose of this medicine is 10/40/25mg of amlodipine/olmesartan medoxomil/hydrochlorothiazide. The maximum blood pressure-lowering effect occurs within 2 weeks of administration; therefore, adjust the dose at intervals of 2 weeks or longer, taking the patient's blood pressure response into account. The recommended doses are as follows. - 5/20/12.5mg: Administer to patients whose blood pressure is not adequately controlled with amlodipine/olmesartan medoxomil 5/20mg combination therapy. - 5/40/12.5mg: Administer to patients whose blood pressure is not adequately controlled with amlodipine/olmesartan medoxomil 5/40mg combination therapy or this medicine 5/20/12.5mg. - 5/40/25mg: Administer to patients whose blood pressure is not adequately controlled with this medicine 5/40/12.5mg. - 10/40/12.5mg: Administer to patients whose blood pressure is not adequately controlled with amlodipine/olmesartan medoxomil 10/40mg combination therapy or this medicine 5/40/12.5mg. - 10/40/25mg: Administer to patients whose blood pressure is not adequately controlled with this medicine 5/40/25mg or this medicine 10/40/12.5mg. ※ Refer to the following dose escalation schedule. (The content of each ingredient is listed in the order of amlodipine/olmesartan medoxomil/hydrochlorothiazide.) 5/20/0mg → 5/20/12.5mg ↓ 5/40/0mg → 5/40/12.5mg → 5/40/25mg ↓ ↓ 10/40/0mg → 10/40/12.5mg → 10/40/25mg ٠ Patients with renal impairment The maximum dose of this medicine for patients with mild or moderate renal impairment (creatinine clearance 30-60mL/min) is 20/5/12.5 milligrams once daily. For patients with moderate renal impairment, monitoring of potassium and creatinine levels is recommended. This medicine should not be administered to patients with severe renal impairment (creatinine clearance < 30mL/min). ٠ Patients with hepatic impairment Use with caution in patients with mild or moderate hepatic impairment. The maximum dose of this medicine for patients with moderate hepatic impairment is 5/20/12.5 milligrams once daily. Blood pressure and renal function should be closely monitored in patients with hepatic impairment. This medicine should not be administered to patients with severe hepatic impairment. ٠ Elderly patients (65 years or older) In general, start treatment at a low dose. When adjusting the dose, the patient's renal or cardiac function and comorbidities should be taken into consideration. Blood pressure should be monitored closely and more frequently in elderly patients. Since experience with the use of this medicine in elderly patients, particularly those aged 75 years or older, is very limited, monitor them very carefully when administering this medicine.
The safety and efficacy of this drug in pediatric patients under 18 years of age have not been established; its use is not recommended.
This drug can cause serious harm to the fetus and newborn during the second and third trimesters of pregnancy, so it should be discontinued immediately upon confirmation of pregnancy. Patients with allergies to this drug or its components, or those with specific heart, kidney, or liver diseases should not use it. Patients with excessively low blood pressure or acute heart failure should not take this medication. Patients with low blood volume or salt may experience symptoms of hypotension when starting this drug, so careful monitoring is required. Patients with impaired kidney function or those who have undergone kidney transplantation should regularly check kidney function and electrolyte status through blood tests while taking this medication. This drug is not recommended for patients with severe liver dysfunction. Elderly patients, those with certain heart valve diseases, systemic lupus erythematosus, gout, or diabetes history should also use it with caution. Since this drug lowers blood pressure, caution should be exercised regarding dizziness or drowsiness when driving or operating dangerous machinery. Additionally, this drug may interact with other antihypertensive drugs, diuretics, lithium formulations, etc., so it is essential to inform the healthcare provider about any other medications being taken. It is important to periodically check the electrolyte levels, such as potassium, sodium, calcium, and kidney function through blood tests while taking this drug. Rare side effects such as skin rashes, headaches, dizziness, swelling, and dyspepsia may occur, and any unusual symptoms should be reported to a physician immediately. The use of this drug is not recommended during pregnancy or breastfeeding; safer alternatives should be considered if necessary. In case of overdose, severe hypotension or cardiac problems may occur, and immediate medical attention is required.
Peripheral edema, headache, dizziness, upper respiratory tract infection, nasopharyngitis, urinary tract infection, sialadenitis, leukopenia, thrombocytopenia, bone marrow suppression, neutropenia, agranulocytosis, hemolytic anemia, aplastic anemia, anaphylactic reaction, drug hypersensitivity, hyperkalemia, hypokalemia, anorexia, diabetes, hypercalcemia, hyperglycemia, hypomagnesemia, hyponatremia, hypochloremia, hypertriglyceridemia, hypercholesterolemia, hyperuricemia, hypochloremic alkalosis, hyperamylasemia, altered mental state, depression, apathy, sensitivity to stimuli, anxiety, mood changes, sleep disturbances, orthostatic dizziness, syncope, taste disorder, hypertonia, sensory loss, paresthesia, peripheral neuropathy, drowsiness, fainting, seizures, loss of appetite, tremor, visual disturbances, reduced tearing, worsening myopia, jaundice, vertigo, tinnitus, palpitations, tachycardia, myocardial infarction, arrhythmia, angina pectoris, hypotension, flushing, orthostatic hypotension, vasculitis, thrombosis, embolism, cough, bronchitis, dyspnea, pharyngitis, rhinitis, acute interstitial pneumonia, respiratory distress syndrome, pulmonary edema, diarrhea, nausea, constipation, dry mouth, abdominal pain, change in bowel habits, bloating, dyspepsia, gastritis, gastric discomfort, gastroenteritis, gingival hyperplasia, paralytic ileus, pancreatitis, vomiting, hepatitis, jaundice, acute cholecystitis, autoimmune hepatitis, hair loss, angioedema, allergic dermatitis, erythema multiforme, erythema, lupus erythematosus-like skin reaction, pustular rash, exfoliative dermatitis, hyperhidrosis, photosensitivity reaction, pruritus, purpura, Quincke's edema, rash, recurrence of lupus erythematosus, toxic skin necrosis, Stevens-Johnson syndrome, urticaria, muscle cramps, joint swelling, muscle weakness, ankle edema, arthralgia, arthritis, low back pain, paraplegia, myalgia, bone pain, frequent urination, acute renal failure, hematuria, urinary dysfunction, nocturia, interstitial nephritis, renal failure, erectile dysfunction, gynecomastia, asthenia, fatigue, chest pain, fever, influenza-like symptoms, lethargy, malaise, edema, pain, facial edema, elevated blood creatinine, elevated blood urea, elevated blood uric acid, decreased blood potassium, elevated gamma-glutamyl transferase, elevated alanine aminotransferase, elevated aspartate aminotransferase, elevated liver enzymes, elevated blood creatine phosphokinase, weight loss, weight gain, rhabdomyolysis, chronic malabsorption syndrome, intestinal vascular edema, altered consciousness, eczema, limb pain, mild decrease in average hemoglobin and hematocrit levels, chronic malabsorption syndrome-like intestinal disease, acute respiratory distress syndrome, non-cardiogenic pulmonary edema
Not everyone experiences these, and they can vary from person to person.
This drug should be stored in a tightly closed container to avoid exposure to air or moisture, preferably at temperatures between 1 degree and 30 degrees Celsius. Proper storage will help maintain the drug's effectiveness.
White and orange round film-coated tablet
30 tablets/box [10 tablets/Alu-Alu*3]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationOlmesartan Medoxomil 20mg · Amlodipine Besylate 6.944mg +1 more
Tablet · Prescription medication · Combination
Aju Pharmaceuticals Co., Ltd.
CombinationOlmesartan Medoxomil 40mg · Amlodipine Besylate 6.944mg +1 more
Tablet · Prescription medication · Combination
Hanmi Daiichi Sankyo Co., Ltd.
CombinationOlmesartan Medoxomil 40mg · Amlodipine Besylate 13.888mg +1 more
Tablet · Prescription medication · Combination
Daicel Corporation (Co., Ltd.)
CombinationOlmesartan Medoxomil 20mg · Amlodipine Besylate 6.944mg +1 more
Tablet · Prescription medication · Combination
HanKook Daiichi Sankyo Co., Ltd.
Olmesartan Medoxomil · Amlodipine Besylate +1 more
Prescription medication · Combination
SYNEX Co., Ltd.
Olmesartan Medoxomil · Amlodipine Besylate +1 more
Prescription medication · Combination
SYNEX Co., Ltd.
Olmesartan Medoxomil · Amlodipine Besylate +1 more
Prescription medication · Combination
SYNEX Co., Ltd.
CombinationAmlodipine Besylate 6.944mg · Olmesartan Medoxomil 20mg +1 more
Tablet · Prescription medication · Combination
JW Pharmaceutical Corporation
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.